Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.

Lampignano R, Neumann MHD, Weber S, Kloten V, Herdean A, Voss T, Groelz D, Babayan A, Tibbesma M, Schlumpberger M, Chemi F, Rothwell DG, Wikman H, Galizzi JP, Bergheim IR, Russnes H, Mussolin B, Bonin S, Voigt C, Musa H, Pinzani P, Lianidou E, Brady G, Speicher MR, Pantel K, Betsou F, Schuuring E, Kubista M, Ammerlaan W, Sprenger-Haussels M, Schlange T, Heitzer E; Innovative Medicines Initiative CANCER-ID Consortium.

Clin Chem. 2019 Oct 18. pii: clinchem.2019.306837. doi: 10.1373/clinchem.2019.306837. [Epub ahead of print]

PMID:
31628139
2.

Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing.

Hellwig S, Nix DA, Gligorich KM, O'Shea JM, Thomas A, Fuertes CL, Bhetariya PJ, Marth GT, Bronner MP, Underhill HR.

PLoS One. 2018 Jul 25;13(7):e0197333. doi: 10.1371/journal.pone.0197333. eCollection 2018.

3.

Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience.

Malentacchi F, Pizzamiglio S, Verderio P, Pazzagli M, Orlando C, Ciniselli CM, Günther K, Gelmini S.

Clin Chem Lab Med. 2015 Nov;53(12):1935-42. doi: 10.1515/cclm-2014-1161.

PMID:
25883202
4.

Circulating cell free DNA: Preanalytical considerations.

El Messaoudi S, Rolet F, Mouliere F, Thierry AR.

Clin Chim Acta. 2013 Sep 23;424:222-30. doi: 10.1016/j.cca.2013.05.022. Epub 2013 May 30. Review.

PMID:
23727028
5.

Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.

Chen Z, Zhang S, Li C, Xu C, Zhao J, Miao L.

Genet Test Mol Biomarkers. 2019 Apr;23(4):270-276. doi: 10.1089/gtmb.2018.0106.

PMID:
30986099
6.

Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony® SP Instrument.

Wolf A, Beller K, Groemminger S, Hofmann W, Sachse M, Fassunke J.

Adv Exp Med Biol. 2016;924:179-185.

PMID:
27753041
7.

A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.

Sorber L, Zwaenepoel K, Deschoolmeester V, Roeyen G, Lardon F, Rolfo C, Pauwels P.

J Mol Diagn. 2017 Jan;19(1):162-168. doi: 10.1016/j.jmoldx.2016.09.009. Epub 2016 Nov 17.

PMID:
27865784
8.

Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.

Kloten V, Neumann MHD, Di Pasquale F, Sprenger-Haussels M, Shaffer JM, Schlumpberger M, Herdean A, Betsou F, Ammerlaan W, Af Hällström T, Serkkola E, Forsman T, Lianidou E, Sjöback R, Kubista M, Bender S, Lampignano R, Krahn T, Schlange T; CANCER-ID consortium.

Clin Chem. 2019 Sep;65(9):1132-1140. doi: 10.1373/clinchem.2019.303271. Epub 2019 Jun 24.

PMID:
31235535
9.

Isolation of Cell-Free DNA from Maternal Plasma.

Stray J, Zimmermann B.

Methods Mol Biol. 2019;1885:309-323. doi: 10.1007/978-1-4939-8889-1_21.

PMID:
30506207
10.

Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.

Schmidt B, Reinicke D, Reindl I, Bork I, Wollschläger B, Lambrecht N, Fleischhacker M.

Clin Chim Acta. 2017 Jun;469:94-98. doi: 10.1016/j.cca.2017.03.031. Epub 2017 Mar 31. Erratum in: Clin Chim Acta. 2017 Jun;469:208.

PMID:
28373054
11.

Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.

Mouliere F, El Messaoudi S, Pang D, Dritschilo A, Thierry AR.

Mol Oncol. 2014 Jul;8(5):927-41. doi: 10.1016/j.molonc.2014.02.005. Epub 2014 Mar 24.

12.

Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNA.

Shi X, Duose DY, Mehrotra M, Harmon MA, Hu P, Wistuba II, Kopetz S, Luthra R.

Cancer Genet. 2019 Sep;237:82-89. doi: 10.1016/j.cancergen.2019.06.004. Epub 2019 Jun 12.

PMID:
31447070
13.

Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.

Vietsch EE, Graham GT, McCutcheon JN, Javaid A, Giaccone G, Marshall JL, Wellstein A.

Cancer Genet. 2018 Dec;228-229:131-142. doi: 10.1016/j.cancergen.2018.11.001. Epub 2018 Nov 9.

PMID:
30447903
14.

Circulating cell-free DNA in patients with alveolar echinococcosis.

Baraquin A, Hervouet E, Richou C, Flori P, Peixoto P, Azizi A, Delabrousse E, Blagosklonov O, Umhang G, Bresson-Hadni S, Valot B, Grenouillet F; EchinoVista study group.

Mol Biochem Parasitol. 2018 Jun;222:14-20. doi: 10.1016/j.molbiopara.2018.04.004. Epub 2018 Apr 18.

PMID:
29679605
15.

Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.

Warton K, Yuwono NL, Cowley MJ, McCabe MJ, So A, Ford CE.

Mol Diagn Ther. 2017 Oct;21(5):563-570. doi: 10.1007/s40291-017-0284-x.

PMID:
28631163
16.

Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.

Salvianti F, Massi D, De Giorgi V, Gori A, Pazzagli M, Pinzani P.

Cancer Biomark. 2019;26(3):271-279. doi: 10.3233/CBM-181647.

PMID:
31524142
17.

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

Mouliere F, El Messaoudi S, Gongora C, Guedj AS, Robert B, Del Rio M, Molina F, Lamy PJ, Lopez-Crapez E, Mathonnet M, Ychou M, Pezet D, Thierry AR.

Transl Oncol. 2013 Jun 1;6(3):319-28. Print 2013 Jun.

18.

Comparison of the quantification of KRAS mutations by digital PCR and E-ice-COLD-PCR in circulating-cell-free DNA from metastatic colorectal cancer patients.

Sefrioui D, Mauger F, Leclere L, Beaussire L, Di Fiore F, Deleuze JF, Sarafan-Vasseur N, Tost J.

Clin Chim Acta. 2017 Feb;465:1-4. doi: 10.1016/j.cca.2016.12.004. Epub 2016 Dec 7.

19.

Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.

Mauger F, Dulary C, Daviaud C, Deleuze JF, Tost J.

Anal Bioanal Chem. 2015 Sep;407(22):6873-8. doi: 10.1007/s00216-015-8846-4. Epub 2015 Jun 28.

PMID:
26123439
20.

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.

Medina Diaz I, Nocon A, Mehnert DH, Fredebohm J, Diehl F, Holtrup F.

PLoS One. 2016 Nov 10;11(11):e0166354. doi: 10.1371/journal.pone.0166354. eCollection 2016.

Supplemental Content

Support Center